Publication Interventions for erythema nodosum leprosum. Van Veen NH J, Lockwood DN, van Brakel WH, et al. The Cochrane database of systematic reviews. 2009; Download PDF
Publication Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein. Mukai T, Maeda Y, Tamura T, et al. Journal of immunology (Baltimore, Md. : 1950). 2009; 183 (10) : 6561-8.
Publication Ocular manifestation in treated multibacillary Hansen's disease. Parikh R, Thomas S, Muliyil J, et al. Ophthalmology. 2009; 116 (11) : 2051-7.e1.
Publication Porphyria cutanea tarda. Ghosh S K, Bandyopadhyay D, Chatterjee G, et al. The Journal of the Association of Physicians of India. 2008;
Publication Immunostimulatory activity of recombinant Mycobacterium bovis BCG that secretes major membrane protein II of Mycobacterium leprae. Makino M, Maeda Y, Inagaki K. Infection and immunity. 2006; 74 (11) : 6264-71.
Publication Preventable causes of blindness. Onyango-Ogony P J. East African medical journal. 2006; 83 (4) : 61-2.
Publication Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes. Brabin BJ, Eggelte TA, Parise M, et al. Drug safety. 2004; 27 (9) : 633-48.
Publication Prevalence of glaucoma in treated multibacillary Hansen disease. Thomas R, Thomas S, Muliyil J. Journal of glaucoma. 2003; 12 (1) : 16-22.
Publication [Pharmaceutical development concerning diseases predominating in tropical regions: the concept of indigent drugs]. Trouiller P, Rey J L, Bouscharain P. Annales pharmaceutiques francaises. 2000; 58 (1) : 43-6.
Publication Seizures following chloroquine treatment of type II lepra reaction: a case report. Ebenso B E. Leprosy review. 1998; 69 (2) : 178-81. Download PDF
Publication Expression of mycobacterial antigens on murine dissociated Schwann cells infected with Mycobacterium leprae. Birdi T J, D'Souza S, Antia N H. Microbial pathogenesis. 1997; 22 (3) : 181-5.
Publication Dapsone in rheumatoid arthritis. Chang D J, Lamothe M, Stevens R M, et al. Seminars in arthritis and rheumatism. 1996; 25 (6) : 390-403.
Publication Clofazimine induced cardiotoxicity--a case report. Choudhri S H, Harris L, Butany J W, et al. Leprosy review. 1995; 66 (1) : 63-8. Download PDF
Publication Major histocompatibility complex non-restricted presentation to CD4+ T lymphocytes of Mycobacterium leprae heat-shock protein 65 antigen by macrophages transfected with the mycobacterial gene. Silva C L, Lukacs K, Lowrie D B. Immunology. 1993; 78 (1) : 35-42.
Publication Tumor necrosis factor: status in reactions in leprosy before and after treatment. Bhattacharya S N, Chattopadhaya D, Saha K. International journal of dermatology. 1993; 32 (6) : 436-9.
Publication Shoreline nails following type II lepra reaction. Pavithran K. Indian journal of leprosy. 1993; 65 (2) : 225-7.
Publication Anti-leprosy drugs inhibit the complement-mediated solubilization of pre-formed immune complexes in vitro. Kashyap A, Sehgal V N, Sahu A, et al. International journal of immunopharmacology. 1992; 14 (2) : 269-73.
Publication Treatment of leprosy. Kulkarni A G. The National medical journal of India. 1992; 5 (2) : 96.
Publication Reconstruction of anti-leprosy drug depleted complement haemolytic activity by addition of zymosan-treated sera (a source of C142) and CratEDTA (a source of C3-C9). Kashyap A, Saha K, Sehgal V N. International journal of immunopharmacology. 1992; 14 (8) : 1409-14.
Publication Public-health epidemiology in Vanuatu. Bastien P. The Medical journal of Australia. 1990; 152 (1) : 13-7.
